Mutagenesis associated with nitric oxide production in transgenic SJL mice - PubMed (original) (raw)

Mutagenesis associated with nitric oxide production in transgenic SJL mice

A Gal et al. Proc Natl Acad Sci U S A. 1996.

Abstract

We recently reported development of an experimental model for the study of nitric oxide (NO.) toxicology in vivo. SJL mice were injected with superantigen-bearing RcsX (pre-B-cell lymphoma) cells, which migrated to the spleen and lymph nodes, where their rapid growth induced activation of macrophages to produce large amounts of NO. over a period of several weeks. In the experiments described here, we used this model to investigate mutagenesis in splenocytes exposed to NO. during RcsX cell growth. Transgenic mice were produced by crossbreeding animals of the pUR288 transgenic C57BL/6 and SJL strains. RcsX cells were injected into F1 mice and NO. production was confirmed by quantification of urinary nitrate, the ultimate metabolite of NO. Mutant frequency in the lacZ gene of the pUR288 plasmid was determined in DNA isolated from spleen (target) and kidney (nontarget) tissues. A significant elevation in mutant frequency was found in the spleen, but not in the kidney, of tumor-bearing mice. Furthermore, increases in mutant frequency in the spleen as well as NO. production were abrogated by administration of N-methylarginine, a NO. inhibitor, to mice following injection of RcsX cells. These results indicate that NO. had mutagenic activity in RcsX tumor-bearing mice and thus support a possible role for its involvement in the carcinogenic process.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Nitrate excretion by RcsX bearing SJL#60 mice and controls. Twelve SJL mice were injected i.v. on day 1 with 107 RcsX cells. Eight RcsX-bearing and eight control mice received 30 mM NMA in drinking water starting on day 2. All mice were killed on day 20.

Figure 2

Figure 2

LacZ mutant frequency in the spleen of RcsX tumor-bearing SJL#60 mice.

Similar articles

Cited by

References

    1. Gordon L I, Weitzman S A. Cancer J. 1993;6:257–261.
    1. Ohshima H, Bartsch H. Mutat Res. 1994;305:253–264. - PubMed
    1. Ames B N, Shigenaga M K, Hagen T M. Proc Natl Acad Sci USA. 1993;90:7915–7922. - PMC - PubMed
    1. Trush M A, Kensler T W. Free Radicals Biol Med. 1991;10:201–209. - PubMed
    1. Haswell-Elkins M R, Satarug S, Tsuda M, Mairiang E, Esumi H, Sithithaworn P, Mairiang P, Saaitoh M, Yongvanit P, Elkins D B. Mutat Res. 1994;305:241–252. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources